Patient satisfaction measurement in the disease management industry.
In mid-2004, the Disease Management Association of America (DMAA) Patient Satisfaction Workgroup in association with J.D. Power and Associates (JDPA) conducted a literature review and a member survey to gain an understanding of the nature of patient satisfaction measurement as it pertains to disease management (DM) programs within the DM industry. A review of the relevant literature indicates that perhaps, with the exception of diabetes disease management, there are no prevalent, systematic, or statistically validated approaches for measuring patient satisfaction within the disease management industry. Most existing studies tend to focus on the effectiveness of a disease management program on clinical outcomes, with patient satisfaction measured only as a part of a battery of "outcome" measures. However, many of these studies do find positive associations between patient satisfaction and clinical outcomes. A majority of the 49 respondents who completed the member feedback survey hold relatively high positions in their organizations. The vast majority of respondents indicate their organizations conduct patient satisfaction surveys that assess overall satisfaction, satisfaction with materials and information provided, and with staff members. Patient satisfaction surveys are most common among the five common chronic diseases: diabetes, asthma, congestive heart failure (CHF), coronary artery disease (CAD), and chronic obstructive pulmonary disease (COPD). More than three in four respondents agree that patient satisfaction measurement is important to the long-term success of their programs. Respondents also indicate that along with intelligence on patients' overall satisfaction with the program, they would also like to gain an understanding of whether or not their programs actually help manage the patient's medical condition. Eight survey instruments currently in use and submitted by study participants were also reviewed. Most of these instruments are relatively short and basic, typically administered by mail, and vary in the types of questions and response categories presented to respondents. This research concludes that there exists an implied need for patient satisfaction measurement in the DM industry and an opportunity to develop and leverage a standardized measurement approach assessing patient satisfaction. Additionally, the authors suggest that there may be value to conceptualizing "patient satisfaction" not as an outcome in itself, but as a means to increase compliance, which, in turn, can improve medical outcomes.
Sen
Shaikat
S
J.D. Power and Associates, Mesa, Arizona, USA.
Fawson
Paul
P
Cherrington
Graham
G
Douglas
Kathleen
K
Friedman
Neal
N
Maljanian
Rose
R
Fitzner
Karen
K
Tang
Pei
P
Soper
Steven
S
Wood
Steven
S
D001249:Asthma / Q000523:psychology; D001294:Attitude to Health; D001416:Back Pain / Q000523:psychology; D003327:Coronary Disease / Q000523:psychology; D003550:Cystic Fibrosis / Q000523:psychology; D003920:Diabetes Mellitus / Q000523:psychology; D019468:Disease Management; D005246:Feedback; D019981:Health Care Sector; D006302:Health Services Research; D006333:Heart Failure / Q000523:psychology; D006801:Humans; D007676:Kidney Failure, Chronic / Q000523:psychology; D009369:Neoplasms / Q000523:psychology; D017060:Patient Satisfaction; D011369:Professional-Patient Relations; D029424:Pulmonary Disease, Chronic Obstructive / Q000523:psychology; D035583:Rare Diseases / Q000523:psychology; D016896:Treatment Outcome